19^th International Conference on Diabetes, Nutrition, Obesity and Eating Disorders August 21-22, 2020 Florence, Italy

Dr. Xu is a Full Professor in Beijing Normal University-Hong Kong Baptist University United International College (UIC, a full English teaching college in China), Zhuhai Scholar Distinguished Professor, Program Director of Food Science and Technology Program, Associate Director of UIC Key Lab -Laboratory for Health Promotion Mechanism of Medicinal Food and Folk Remedy, author of 182 peer-reviewed papers. Dr. Xu received Ph.D in Food Science from Chungnam National University, South Korea. He conducted postdoctoral research work in North Dakota State University (NDSU), Purdue University, and Gerald P. Murphy Cancer Foundation in USA during 2005-2009. He did short-term (two months) visiting research in NDSU in 2012, and University Georgia in 2014, and followed by visiting research during his sabbatical leave (7 months) in Pennsylvania State University in USA in 2016.

The overall goal of his research is to understand health promoting effects of phytochemicals. Specific interests include: 1) Complex relationship among diet, gut microbiota, and human health, 2) health benefits (targeted at aging, cancers, obesity, and diabetes) assessment of phytochemicals from natural products; 3) cellular and molecular mechanisms of bioactive components in disease prevention; 4) Dietary polysaccharides and their functional properties.

Dr. Farid Menaa is an inter- and multi disciplinary professional with worldwide reputation. He has three international post-doctoral terms in Oncology, Dermatology, and Hematology; MBA Entrepreneurship and MD candidate. During his ongoing career, he has mainly contributed to the identification and functions of new human disease-causing genes and variants, formulated natural products for anti-aging and developed innovative theranostic strategies against cancers, cardiovascular diseases, diabetes, obesity and infectious diseases. He has more than 10 years’ experiences either in the academic, hospitals or industrial sectors. As Chief Scientific Officer and Vice-President R&D at Fluorotronics, Inc. he actively participated in the development of the disruptive “Carbon-Fluorine Spectroscopy”.

Dr. Farid Menaa’s research interest includes Preventive Medicine, Personalized Medicine, Translational Medicine, Integrative Medicine, Green Medicine, Nanomedicine, Biotechnology, and Nanotechnology.

DDS - 2007 (School of Dentistry of Araçatuba, São Paulo State University), Specialist in Pediatric Dentistry - 2010 (Hospital for Rehabilitation of Craniofacial Anomalies, University of São Paulo), Specialist in Syndromes and Craniofacial Anomalies - 2013 (Hospital for Rehabilitation of Craniofacial Anomalies, University of São Paulo), MSc in Orofacial Clefts and Related Anomalies - 2014 (Hospital for Rehabilitation of Craniofacial Anomalies, University of São Paulo), Specialist in Health Management - 2016 (Federal University of São Paulo), PhD in Experimental Pathology (in degree) – Department of Pathology and Legal Medicine, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, SP, Brazil.

Marcos Roberto Tovani Palone research interest is Cleft lip and palate, Dentistry, Pathology, Public health, Pediatrics, Global Health